2023 Q1 Form 10-K Financial Statement

#000095017023009716 Filed on March 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $16.61M $13.83M $46.91M
YoY Change 77.54% 83.83% 81.89%
Cost Of Revenue $6.675M $5.147M $20.91M
YoY Change 60.61% 121.57% 181.5%
Gross Profit $9.937M $8.684M $26.00M
YoY Change 91.06% 66.97% 41.6%
Gross Profit Margin 59.82% 62.79% 55.43%
Selling, General & Admin $6.300M $6.419M $21.33M
YoY Change 47.37% 74.57% 43.99%
% of Gross Profit 63.4% 73.92% 82.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $120.0K $136.0K $536.0K
YoY Change -9.77% -18.07% 425.49%
% of Gross Profit 1.21% 1.57% 2.06%
Operating Expenses $6.300M $6.555M $21.86M
YoY Change 47.37% 70.57% 47.61%
Operating Profit $3.894M $2.129M $4.142M
YoY Change 345.03% 56.77% 37.43%
Interest Expense $309.0K $1.001M $6.865M
YoY Change 602.27% -4270.83% -6897.03%
% of Operating Profit 7.94% 47.02% 165.74%
Other Income/Expense, Net
YoY Change
Pretax Income $3.826M $3.130M $11.01M
YoY Change 357.11% 134.63% 267.88%
Income Tax $997.0K -$6.840M -$4.486M
% Of Pretax Income 26.06% -218.53% -40.76%
Net Earnings $2.829M $9.970M $15.49M
YoY Change 338.6% 938.54% 407.47%
Net Earnings / Revenue 17.03% 72.08% 33.02%
Basic Earnings Per Share $0.08 $0.43
Diluted Earnings Per Share $0.08 $0.27 $0.42
COMMON SHARES
Basic Shares Outstanding 36.93M 36.93M 36.02M
Diluted Shares Outstanding 37.33M 37.10M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.73M $12.67M $12.67M
YoY Change 4.21% -7.01% -7.01%
Cash & Equivalents $15.73M $12.67M $12.67M
Short-Term Investments
Other Short-Term Assets $1.129M $1.113M $1.113M
YoY Change -7.76% -23.56% -23.56%
Inventory $3.492M $4.619M $4.619M
Prepaid Expenses
Receivables $978.0K $988.0K $988.0K
Other Receivables $8.506M $4.505M $4.505M
Total Short-Term Assets $30.16M $23.89M $23.89M
YoY Change 24.9% 2.61% 2.61%
LONG-TERM ASSETS
Property, Plant & Equipment $1.638M $4.347M $4.347M
YoY Change 12.5% 195.51% 4.37%
Goodwill $7.446M $7.446M
YoY Change 0.0% 0.0%
Intangibles $4.046M $4.144M
YoY Change -9.28% -9.22%
Long-Term Investments $13.33M $13.97M $13.97M
YoY Change 103.64% 198.38% 198.38%
Other Assets $74.00K $9.513M $9.513M
YoY Change 51.02% 19314.29% 109.68%
Total Long-Term Assets $45.39M $43.67M $43.67M
YoY Change 62.34% 60.66% 60.66%
TOTAL ASSETS
Total Short-Term Assets $30.16M $23.89M $23.89M
Total Long-Term Assets $45.39M $43.67M $43.67M
Total Assets $75.55M $67.56M $67.56M
YoY Change 44.99% 33.88% 33.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.990M $8.924M $8.924M
YoY Change 155.84% -20.63% 3.99%
Accrued Expenses $681.0K $703.0K $703.0K
YoY Change 34.85% 40.32% -77.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.531M $3.411M $3.411M
YoY Change 128.95% 37.6% 37.6%
Total Short-Term Liabilities $21.54M $16.23M $16.23M
YoY Change 40.01% 14.07% 14.07%
LONG-TERM LIABILITIES
Long-Term Debt $748.0K $871.0K $871.0K
YoY Change -39.33% -35.58% -35.58%
Other Long-Term Liabilities $2.033M $2.164M $2.164M
YoY Change -4.42% -3.78% -3.78%
Total Long-Term Liabilities $2.781M $3.035M $3.035M
YoY Change -17.23% -15.72% -15.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.54M $16.23M $16.23M
Total Long-Term Liabilities $2.781M $3.035M $3.035M
Total Liabilities $24.32M $19.26M $19.26M
YoY Change 29.75% 8.06% 8.06%
SHAREHOLDERS EQUITY
Retained Earnings -$242.7M -$245.3M
YoY Change -6.71% -5.94%
Common Stock $371.0K $369.0K
YoY Change 1.09% 0.82%
Preferred Stock
YoY Change
Treasury Stock (at cost) $395.0K $395.0K
YoY Change
Treasury Stock Shares $243.5K $243.5K
Shareholders Equity $51.23M $48.30M $48.30M
YoY Change
Total Liabilities & Shareholders Equity $75.55M $67.56M $67.56M
YoY Change 44.99% 33.88% 33.88%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $2.829M $9.970M $15.49M
YoY Change 338.6% 938.54% 407.47%
Depreciation, Depletion And Amortization $120.0K $136.0K $536.0K
YoY Change -9.77% -18.07% 425.49%
Cash From Operating Activities $8.945M $3.912M $6.483M
YoY Change 189.2% 161.67% -346.41%
INVESTING ACTIVITIES
Capital Expenditures $89.00K $121.0K $215.0K
YoY Change 641.67% -6150.0% -84.91%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$6.697M -$11.27M -$7.301M
YoY Change 593.27% 283.55% -16.77%
Cash From Investing Activities -$6.786M -$11.39M -$7.516M
YoY Change 593.87% 287.41% -26.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 907.0K 2.659M 78.00K
YoY Change -241.72% 45.14% -97.46%
NET CHANGE
Cash From Operating Activities 8.945M 3.912M 6.483M
Cash From Investing Activities -6.786M -11.39M -7.516M
Cash From Financing Activities 907.0K 2.659M 78.00K
Net Change In Cash 3.066M -4.815M -955.0K
YoY Change 107.86% -1340.98% -90.22%
FREE CASH FLOW
Cash From Operating Activities $8.945M $3.912M $6.483M
Capital Expenditures $89.00K $121.0K $215.0K
Free Cash Flow $8.856M $3.791M $6.268M
YoY Change 187.44% 153.24% -254.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000849145
CY2019 us-gaap Open Tax Year
OpenTaxYear
2019
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39471
CY2022 dei Entity Registrant Name
EntityRegistrantName
HERITAGE GLOBAL INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2291344
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
12625 High Bluff Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 305
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
CY2022 dei City Area Code
CityAreaCode
858
CY2022 dei Local Phone Number
LocalPhoneNumber
847-0659
CY2022 dei Security12g Title
Security12gTitle
Common stock, $0.01 par value
CY2022 dei Trading Symbol
TradingSymbol
HGBL
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
42300000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36932177
CY2022 dei Auditor Firm
AuditorFirmId
1195
CY2021 dei Auditor Firm
AuditorFirmId
23
CY2022 dei Auditor Name
AuditorName
UHY LLP
CY2022 dei Auditor Location
AuditorLocation
West Des Moines, Iowa
CY2021 dei Auditor Name
AuditorName
BAKER TILLY US, LLP
CY2021 dei Auditor Location
AuditorLocation
San Diego, California
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12667000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13622000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
122000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
988000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2732000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
4505000
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2254000
CY2022Q4 us-gaap Inventory Net
InventoryNet
4619000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3220000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1113000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1456000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
23892000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
23284000
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4245000
CY2021Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1784000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
13973000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4683000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2776000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2694000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1571000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1471000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4144000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4565000
CY2022Q4 us-gaap Goodwill
Goodwill
7446000
CY2021Q4 us-gaap Goodwill
Goodwill
7446000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9449000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4488000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49000
CY2022Q4 us-gaap Assets
Assets
67560000
CY2021Q4 us-gaap Assets
Assets
50464000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8924000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4793000
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
3188000
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
6451000
CY2022Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
3411000
CY2021Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
2479000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
703000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
501000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16226000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14224000
CY2022Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
871000
CY2021Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1352000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2164000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2249000
CY2022Q4 us-gaap Liabilities
Liabilities
19261000
CY2021Q4 us-gaap Liabilities
Liabilities
17825000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
565
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
565
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
565
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
565
CY2022Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2021Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36932177
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36932177
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36574702
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36574702
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
369000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
366000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293589000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293030000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-245270000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-260763000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
243468
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
395000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
48299000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32639000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67560000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50464000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46914000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25792000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21326000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
460000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4961000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-86000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
540000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
408000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1744000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
826000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1399000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2487000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-328000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
749000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4129000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-557000
CY2022 hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
-3263000
CY2021 hgbl Increase Decrease Of Payables To Sellers
IncreaseDecreaseOfPayablesToSellers
-2538000
CY2022 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-513000
CY2021 hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-61000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6483000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2631000
CY2022 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
8435000
CY2021 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
8039000
CY2022 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3446000
CY2021 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3984000
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
14612000
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2603000
CY2022 hgbl Return Of Investment In Equity Method Investments
ReturnOfInvestmentInEquityMethodInvestments
5309000
CY2021 hgbl Return Of Investment In Equity Method Investments
ReturnOfInvestmentInEquityMethodInvestments
0
CY2022 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
6991000
CY2021 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
243000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
215000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1425000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4318000
CY2022 hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
0
CY2021 hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
1961000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7516000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10197000
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2880000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5248000
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2429000
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1417000
CY2022 hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
66000
CY2021 hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
221000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
44000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
987000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
395000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
978350
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
78000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3065000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-955000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9763000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13622000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23385000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12667000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13622000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
297000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
116000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
103000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
22000
CY2022 hgbl Noncash Change In Right Of Use Assets
NoncashChangeInRightOfUseAssets
630000
CY2021 hgbl Noncash Change In Right Of Use Assets
NoncashChangeInRightOfUseAssets
2263000
CY2022 hgbl Noncash Change In Lease Liabilities
NoncashChangeInLeaseLiabilities
630000
CY2021 hgbl Noncash Change In Lease Liabilities
NoncashChangeInLeaseLiabilities
2263000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant estimates include the assessment of collectability of revenue recognized and the valuation of accounts receivable and notes receivable, inventory, investments, goodwill and intangible assets, liabilities, deferred income tax assets and liabilities including projecting future years’ taxable income, and stock-based compensation. These estimates have the potential to significantly impact our consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year balances within the consolidated financial statements have been reclassified to conform to current year presentation.</span>
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
0
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
600000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
600000
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.60
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.62
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9400000
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
29788000
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3285000
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.09
CY2021 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.09
CY2022Q4 hgbl Impaired Financing Receivables Unpaid Principal Balance
ImpairedFinancingReceivablesUnpaidPrincipalBalance
8800000
CY2022 us-gaap Notes Issued1
NotesIssued1
8400
CY2022 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
3400000
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
400000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
4172000
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
2079000
CY2022 hgbl Origination Of Notes Receivable
OriginationOfNotesReceivable
8435000
CY2021 hgbl Origination Of Notes Receivable
OriginationOfNotesReceivable
8039000
CY2021 hgbl Transfer Of Notes To And From Senior Lender
TransferOfNotesToAndFromSeniorLender
-1961000
CY2022 hgbl Principal Payment Of Note Receivable
PrincipalPaymentOfNoteReceivable
3446000
CY2021 hgbl Principal Payment Of Note Receivable
PrincipalPaymentOfNoteReceivable
3985000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
9161000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
4172000
CY2022 hgbl Deferred Finance Fees And Costs Net
DeferredFinanceFeesAndCostsNet
-411000
CY2021 hgbl Deferred Finance Fees And Costs Net
DeferredFinanceFeesAndCostsNet
-134000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
8750000
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
4038000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
0
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
0
CY2019Q2 us-gaap Sale Leaseback Transaction Date
SaleLeasebackTransactionDate
The purchase option for both the real estate and machinery and equipment could be exercised at any time on or after December 1, 2019, and before May 31, 2021,
CY2019Q2 us-gaap Sale Leaseback Transaction Net Book Value
SaleLeasebackTransactionNetBookValue
20000000.0
CY2022 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
the Company’s shares of Series N preferred stock, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2022Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
40
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36016619
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35458938
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1080651
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1442452
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37097270
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36901390
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000
CY2022 hgbl Number Of Locations
NumberOfLocations
4
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2776000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2694000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2867000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2750000
CY2019Q1 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0525
CY2021Q2 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0495
CY2022Q3 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.055
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
681000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
543000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
704000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
674000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
546000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
531000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
496000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
312000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3263000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
396000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2867000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1789000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1574000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
218000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
103000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1571000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1471000
CY2022 us-gaap Depreciation
Depreciation
100000
CY2021 us-gaap Depreciation
Depreciation
100000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2128000
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
422000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1707000
CY2021Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4565000
CY2022 hgbl Intangible Assets Acquired Excluding Goodwill
IntangibleAssetsAcquiredExcludingGoodwill
0
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
422000
CY2022Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4144000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
686000
CY2021 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
1800000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
358000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2128000
CY2020Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
3123000
CY2021 hgbl Intangible Assets Acquired Excluding Goodwill
IntangibleAssetsAcquiredExcludingGoodwill
1800000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
358000
CY2021Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4565000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2022Q4 us-gaap Acquired Finite Lived Intangible Asset Residual Value
AcquiredFiniteLivedIntangibleAssetResidualValue
0
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
391000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
391000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
263000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
186000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
32000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
444000
CY2022Q4 hgbl Finite Lived Intangible Asset Net
FiniteLivedIntangibleAssetNet
1707000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1895437
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.48
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
106313
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.79
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
150000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.61
CY2022Q4 us-gaap Goodwill
Goodwill
7446000
CY2021Q4 us-gaap Goodwill
Goodwill
7446000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4660000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1904000
CY2022Q4 hgbl Accrued Asset Liquidation Expenses
AccruedAssetLiquidationExpenses
2573000
CY2021Q4 hgbl Accrued Asset Liquidation Expenses
AccruedAssetLiquidationExpenses
1327000
CY2022Q4 hgbl Due To Joint Venture Partners Current
DueToJointVenturePartnersCurrent
793000
CY2021Q4 hgbl Due To Joint Venture Partners Current
DueToJointVenturePartnersCurrent
402000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
279000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
407000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
220000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
177000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
204000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
184000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
195000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
392000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8924000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4793000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2027350
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.38
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2193288
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.23
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1023975
CY2022Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
3411000
CY2021Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
2479000
CY2022Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
871000
CY2021Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
1352000
CY2022Q4 us-gaap Loans Payable
LoansPayable
4282000
CY2021Q4 us-gaap Loans Payable
LoansPayable
3831000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13097000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-855000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12242000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-7813000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4429000
CY2022Q4 hgbl Additional Deferred Tax Assets Realizable Amount
AdditionalDeferredTaxAssetsRealizableAmount
7100000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
64900000
CY2022 hgbl Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
These net operating loss carry forwards begin to expire in 2024.
CY2019 us-gaap Open Tax Year
OpenTaxYear
2019
CY2021 us-gaap Open Tax Year
OpenTaxYear
2021
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2311000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
628000
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
470000
CY2021 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
43000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-179000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-707000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-7813000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-855000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
725000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
830000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4486000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14097000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16824000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
317000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1095000
CY2022Q4 hgbl Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
742000
CY2021Q4 hgbl Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
719000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
280000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
262000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15436000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18900000
CY2022Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
0
CY2021Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
479000
CY2022Q4 hgbl Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
-718000
CY2021Q4 hgbl Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
-704000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
127000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
246000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1558000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2170000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
13878000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
16730000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4429000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12242000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
9449000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4488000
CY2022 hgbl Reduction In Deferred Tax Assets
ReductionInDeferredTaxAssets
4400000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4400000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.97
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000
CY2022Q4 hgbl Preferred Stock Conversion Price Per Share
PreferredStockConversionPricePerShare
1000
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
120
CY2022 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
339125
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1895437
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.02
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.03
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.01
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7M6D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2193288
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.23
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3516225
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.63
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
279500
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.62
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
722500
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.28
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
339125
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.50
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14811000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
536000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
460000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
42772000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
22699000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6978000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
11120000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
3014000
CY2022 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
113000
CY2021 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
22000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11007000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2992000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4486000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15493000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3053000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36016619
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35458938
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37097270
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36901390
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
29943000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-765000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
76000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
332000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3053000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32639000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
134000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
406000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
395000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15493000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
48299000
CY2022 us-gaap Profit Loss
ProfitLoss
15493000
CY2021 us-gaap Profit Loss
ProfitLoss
3053000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
279000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
141000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6978000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-79000
CY2022 hgbl Noncash Lease Expense
NoncashLeaseExpense
548000
CY2021 hgbl Noncash Lease Expense
NoncashLeaseExpense
532000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
536000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.59
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1003375
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.80
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1214938
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.96
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1000000.0
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
400000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
200000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2027350
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1023975
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1500000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1300000

Files In Submission

Name View Source Status
0000950170-23-009716-index-headers.html Edgar Link pending
0000950170-23-009716-index.html Edgar Link pending
0000950170-23-009716.txt Edgar Link pending
0000950170-23-009716-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hgbl-20221231.htm Edgar Link pending
hgbl-20221231.xsd Edgar Link pending
hgbl-ex10_41.htm Edgar Link pending
hgbl-ex10_42.htm Edgar Link pending
hgbl-ex10_43.htm Edgar Link pending
hgbl-ex21.htm Edgar Link pending
hgbl-ex23_1.htm Edgar Link pending
hgbl-ex23_2.htm Edgar Link pending
hgbl-ex31_1.htm Edgar Link pending
hgbl-ex31_2.htm Edgar Link pending
hgbl-ex32_1.htm Edgar Link pending
hgbl-ex32_2.htm Edgar Link pending
img160671233_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
hgbl-20221231_def.xml Edgar Link unprocessable
hgbl-20221231_cal.xml Edgar Link unprocessable
hgbl-20221231_pre.xml Edgar Link unprocessable
hgbl-20221231_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hgbl-20221231_lab.xml Edgar Link unprocessable